Skip to main content
Premium Trial:

Request an Annual Quote

EPA Licenses Simulations Plus Software for Drug Toxicity Prediction

NEW YORK (GenomeWeb News) – The US Environmental Protection Agency has licensed Simulations Plus’ ADMET Predictor chemical and toxicity software to help monitor potential drug pollutants in the water supply and in oceans, the company said yesterday.
 
Drugs are a “potential environmental hazard,” said Simulations Plus VP of Marketing and Sales Ron Creeley, “because a large portion of them are thrown away instead of being taken.” When these drugs end up in sewage treatment facilities and landfills they can end up in streams and oceans, he said.
 
Creeley said that it is now important for the EPA, the chemical industry, and drug manufacturers to “consider not only how new molecules accomplish their designed purpose, but also how the environment could be affected if and when they get into our air or water.”
 
He also said that this is the first time the EPA has licensed the firm’s software.
 
Robert Fraczkiewicz, product manager for ADMET Predictor, said the software will “allow the EPA to predict a number of potential toxicities for industry chemicals, agricultural chemicals, and drug molecules plus excipients.”
 
Fraczkiewicz also said that the software’s Enslein Metabolism Module can be used to determine how people will metabolize chemicals.
 

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.